News
NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on developing innovative ...
HONG KONG, April 06, 2025--(BUSINESS WIRE)--Oasis Management Company Ltd. ("Oasis ... of Japanese pharmaceuticals and food products manufacturer Kobayashi Pharmaceutical Co., Ltd. (4967 JT ...
Novo Nordisk, the maker of blockbuster weight loss drug Wegovy ... a CEO succession is in the best interest of the company and its shareholders." Jorgensen will continue as CEO "for a period ...
The vaccine was approved by the U.S. Food and Drug Administration ... according to the company's proxy statement for 2024. The top institutional shareholders of Pfizer as of the end of 2024 ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health ...
The FDA’s Oncologic Drugs Advisory Committee narrowly voted against the approval of Zusduri, citing the lack of a completely ...
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company ...
Shareholders ... company stock that they own. The stock yesterday closed at $34.10 and is up nearly 27 percent this year. The deal is expected to be completed by the end of June. Performance Food ...
Yet food companies from Hershey to Hormel are waving off the impact of GLP-1 drugs, even as they’ve been dropping weight themselves. The volume of food those and other companies sell has ...
Novo Nordisk, the maker of blockbuster weight loss drug Wegovy ... a CEO succession is in the best interest of the company and its shareholders." Jorgensen will continue as CEO "for a period ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results